Project Grant K01CA308852
Award Date 9/1/26
Completion Date 8/31/31
Dollars Obligated $186K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
East Lansing, MI 48824, USA
Similar Awards
- The National Cancer Institute awarded Michigan State University Henry Ford Health+Michigan State University Health Sciences $309,874 on September 1, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to develop and test a fully asynchronous digital intervention for reducing alcohol misuse in adolescent and young adult cancer survivors. The project adapts TRAC-AYA (Tracking and Reducing Alcohol Consumption in AYAs), a technology-based intervention previously developed...
- The National Cancer Institute awarded the Regents of the University of Michigan $293,430 on June 1, 2026, under the Cancer Research Manpower program (CFDA 93.398) to study regional cancer care delivery across hub-and-spoke health systems. The research uses colon cancer as a test case to examine multidisciplinary care coordination within integrated health systems. The project leverages Michigan's Collaborative Quality Initiatives as a learning laboratory and pursues three primary aims:...
- The National Cancer Institute awarded the Regents of the University of Michigan $490,836 on June 19, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to fund research examining transitions from active surveillance to observation in prostate cancer management among older men. The research addresses a clinical gap in understanding how and when men aged 65 and older who are too old or too sick with comorbidities to benefit from cancer treatment transition from active...
- Federal Grant Award Summary The National Cancer Institute awarded the University of Michigan $682,272 under the Cancer Cause and Prevention Research program (CFDA 93.393) on September 1, 2025, for a two-year project (completion date August 31, 2027) to assess the feasibility and acceptability of a multifaceted electronic health record (EHR)-integrated mobile health intervention designed to reduce post-operative readmissions following radical cystectomy. The intervention consists of an...
- The National Cancer Institute awarded Michigan State University Henry Ford Health+Michigan State University Health Sciences $503,896 on August 1, 2026, under the Cancer Biology Research program (CFDA 93.396) to investigate the role of fibroblast glutamate metabolism in immunosuppression in pancreatic ductal adenocarcinoma. The project runs through July 31, 2031, with work performed in East Lansing, Michigan. The Cancer Biology Research program funds fundamental research on cancer causation and...
- The National Cancer Institute awarded Regents of the University of Michigan $785,278 on August 14, 2026, under the Cancer Treatment Research program (CFDA 93.395) to develop and evaluate the efficacy of the MI Sleep Coach App, a mobile cognitive behavioral therapy for insomnia (CBT-I) intervention designed specifically for cancer survivors. Sleep disturbances affect over 50 percent of breast, prostate, and colorectal cancer survivors and are associated with negative effects on physical and...
- The National Cancer Institute awarded Wayne State University $398,544 on August 14, 2026, under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to build and test a clinic-based sleep care pathway for oncology patients with sleep disorders. The project, titled ONC-SLEEP COLLABORATIVE: COMISA COLLABORATIVE CARE INTEGRATION IN ONCOLOGY, addresses comorbid insomnia and obstructive sleep apnea (COMISA) in cancer patients through a team-based collaborative care model. Aim 1...
- Federal Grant Award Summary Michigan State University (through its Henry Ford Health+Michigan State University Health Sciences partnership) received a $153,278 Project Grant from the National Cancer Institute under the Cancer Cause and Prevention Research program (CFDA 93.393) effective July 3, 2025, with completion expected June 30, 2027. The award supports the development of a Dre-Rox recombination-based Genetically Engineered Mouse Model (GEMM) for NUT carcinoma, a rare but aggressive...
- The National Cancer Institute awarded The MGH Institute of Health Professions, Inc. $696,498 on May 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to develop and optimize a multicomponent intervention for improving functional recovery and participation in life roles among breast cancer survivors. The research uses the Multiphase Optimization Strategy (MOST) framework to systematically test three remotely delivered intervention components: priority elicitation to...
- The National Institutes of Health National Cancer Institute awarded Wayne State University $155,000 on May 1, 2026, under the Cancer Cause and Prevention Research program (CFDA 93.393) to investigate multi-level predictors of diagnostic follow-up attendance after an abnormal cervical cancer screen. The project will identify individual-level and clinic-level barriers and facilitators to diagnostic follow-up completion among women who receive abnormal cervical cancer screening results. Current...